INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street — New York, New York

INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street has participated in 1 clinical trials.

Therapeutic areas: Postoperative Pain.

Sponsors: Pacira Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street?

INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street conducted?

INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street has 1 clinical trials on record. Their work covers Postoperative Pain.

Is INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street accredited by Crixeo Health?

INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about INSALL-SCOTT-KELLY INSTITUTE 210 East 64th Street?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.